211 related articles for article (PubMed ID: 36482597)
1. Oral Chinese patent medicines for acute myocardial infarction after percutaneous coronary intervention: A protocol for systematic review and network meta-analysis.
Zhao W; Xiong FJ; Feng SG; Li YM; Lei XH; Jia SJ
Medicine (Baltimore); 2022 Dec; 101(48):e31927. PubMed ID: 36482597
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of traditional Chinese patent medicine for anxiety disorders in children or adolescence: A protocol for systematic review and network meta-analysis.
Jiang Z; Wang J; Yu X; Li C; Shao Y; Wang Z
Medicine (Baltimore); 2020 Sep; 99(39):e22274. PubMed ID: 32991427
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and safety of percutaneous coronary intervention for acute myocardial infarction complicated with chronic renal insufficiency: A protocol of systematic review and meta-analysis.
Luo L; Xu WQ; Zhong RX; Chen F; Fu YL; Zhang P; Xiao SH
Medicine (Baltimore); 2019 Jun; 98(24):e16005. PubMed ID: 31192944
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese medicine injections with activating blood circulation, equivalent effect of anticoagulation or antiplatelet, for acute myocardial infarction: A protocol for the systematic review and meta-analysis of randomized clinical trials.
Li X; Lou Y; Shang JJ; Liu HX; Chen JP; Zhou HW
Medicine (Baltimore); 2022 Jun; 101(24):e29089. PubMed ID: 35713425
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness and safety of Chinese medicines for the treatment of uveitis: A protocol for systematic review and meta-analysis.
Han M; Chen Y; Nong L; Liu Z; Qin Y; Meng H; Chen Y; Wang Z; Jin M
Medicine (Baltimore); 2020 Jun; 99(26):e20766. PubMed ID: 32590753
[TBL] [Abstract][Full Text] [Related]
6. The effect of Huoxue Huayu decoction on restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.
Hou Y; Li X; Wang X; Dong T; Yang J
Medicine (Baltimore); 2022 Jan; 101(4):e28677. PubMed ID: 35089215
[TBL] [Abstract][Full Text] [Related]
7. [Evidence map of clinical research on Chinese patent medicines for post-acute myocardial infarction heart failure].
Zhang CD; Huang JY; Wang YX; Zhu MJ; Xing ZY; Qiu BY
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1673-1682. PubMed ID: 38621951
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of drug-coated balloon in acute myocardial infarction: A protocol for systematic review and meta-analysis.
Yu A; Liu H; Yu H; Xiong X
Medicine (Baltimore); 2023 Mar; 102(13):e33383. PubMed ID: 37000096
[TBL] [Abstract][Full Text] [Related]
9. Hypothermia therapy for the treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis.
Jiang F; Zeng D; Xing K; Yang X
Medicine (Baltimore); 2021 Sep; 100(38):e27338. PubMed ID: 34559157
[TBL] [Abstract][Full Text] [Related]
10. Effects of PCSK9 inhibitors on coronary microcirculation, inflammation and cardiac function in patients with CHD after PCI: a protocol for systematic review and meta-analysis.
Ye X; Wang S; Liu X; Wu Q; Lv Y; Lv Q; Li J; Li L; Yang Y
BMJ Open; 2023 Sep; 13(9):e074067. PubMed ID: 37723117
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Chinese medicines for vitreous hemorrhage: A protocol for systematic review and meta-analysis.
Han M; Liu Z; Nong L; Zi Y; Meng H; Deng Y; Wang ZJ; Jin M
Medicine (Baltimore); 2020 May; 99(19):e20086. PubMed ID: 32384479
[TBL] [Abstract][Full Text] [Related]
12. Network meta-analysis of heat-clearing and detoxifying oral liquid of Chinese medicines in treatment of children's hand-foot-mouth disease: A protocol for systematic review and meta-analysis.
Tang J; Zhang G; Xing J; Yu Y; Han T
Medicine (Baltimore); 2022 Feb; 101(5):e28778. PubMed ID: 35119042
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety of traditional Chinese patent medicine for cognitive dysfunction in diabetic cognitive dysfunction: A protocol for systematic review and Bayesian network meta-analysis.
Wang K; Jiang Z; Yu X; Shao Y; Liu H; Wu S; Kong L; Wang Z
Medicine (Baltimore); 2022 Mar; 101(10):e28946. PubMed ID: 35451386
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors of delirium after percutaneous coronary intervention in individuals hospitalised for acute myocardial infarction: protocol for a systematic review and meta-analysis.
Huang K; Lu J; Zhu Y; Cheng T; Du D; Qian X; Pan H; Wang X; Yang H; Lou S
BMJ Open; 2020 Dec; 10(12):e044564. PubMed ID: 33380487
[TBL] [Abstract][Full Text] [Related]
15. Effects of traditional Chinese exercise on cardiac rehabilitation after percutaneous coronary intervention: study protocol for network meta-analysis of randomised controlled trials.
Luo C; Wen J; Sun W; Li T; Yu X; Zhang T; Zhou X; Wu W; Li R
BMJ Open; 2019 Feb; 9(2):e023096. PubMed ID: 30782873
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of Xinkeshu on coronary artery disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Chen M; Zhong G; Men L; Liu Q; Luan J
Medicine (Baltimore); 2021 Nov; 100(46):e27912. PubMed ID: 34797346
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of non-pharmacological interventions on depressive symptoms in patients with Parkinson's disease: a study protocol for a systematic review and network meta-analysis.
Jiang X; Zhang L; Liu H; Su H; Jiang J; Qiang C; Wang Q; Qu X; Sun W; Bi H
BMJ Open; 2023 May; 13(5):e068019. PubMed ID: 37130665
[TBL] [Abstract][Full Text] [Related]
18. Effect and safety of Chinese patent medicine capsules for recurrent angina pectoris after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Sun Y; Wang Z; Wang C; Tang Z; Shi J; Zhao H
Medicine (Baltimore); 2020 Dec; 99(49):e23287. PubMed ID: 33285705
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of oral Chinese patent medicines as adjuvant treatment for unstable angina pectoris on the national essential drugs list of China: a protocol for a systematic review and network meta-analysis.
Hua Z; Zhai FT; Tian J; Gao CF; Xu P; Zhang F; Liu SJ; Dong K; Du XF; Zhang Z; Yang G
BMJ Open; 2019 Sep; 9(9):e026136. PubMed ID: 31542734
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of Shenfu injection in patients undergoing percutaneous coronary intervention for ST segment elevation myocardial infarction: A protocol for systematic review and meta-analysis.
Yan X; Dong M; Qin X; Li N; Li N
Medicine (Baltimore); 2023 Jan; 102(1):e32483. PubMed ID: 36607881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
